Intramedullary nails are surgical implants used to stabilize bone fragments that result from fractures. Made of titanium or stainless steel, these nails are inserted into the medullary cavity of long bones like the femur, tibia and humerus. The procedure involves creating a small entry point in the proximal and distal segments of the fractured bone and guiding the nail internally to the site of fracture using fluoroscopy for alignment. The nail provides rigid fixation and allows early mobilization and weight bearing. It is commonly used in femoral, tibial and humeral fractures resulting from high-energy trauma like road traffic accidents.

The global intramedullary nail market is estimated to be valued at US$ 1.95 Bn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The estimated high growth of the intramedullary nail market can be attributed to the rising number of road accidents globally. As per the World Health Organization (WHO), road traffic injuries cause around 1.35 million deaths each year. Lower-middle income countries have the highest rates of road traffic deaths per 100,000 population. The use of intramedullary nailing has become the standard of care for treating long bone fractures resulting from road accidents. In addition, growing geriatric population that is prone to osteoporotic fractures is also driving the demand for intramedullary nails. However, high cost of surgery and implants and availability of alternative treatment methods can hinder market growth over the forecast period.

SWOT Analysis

Strength:
- Intramedullary nails offer precise anatomical fittings that allow for improved placement and stabilization of fractures.They are minimally invasive and help in faster recovery.
- Advanced locking mechanism such as fracture-specific targeting devices ensure proper repair of complex fractures.
- Growing adoption of customized intramedullary nails designed as per patient's bone structure.

Weakness:
- Risk of infection at surgical site as it is an invasive procedure.
- Possibility of complications such as bleeding, blood clots if not inserted properly.

Opportunity:
- Rising number of road accidents, fall-related injuries and age-related fractures are increasing demand.
- Development of bioabsorbable implants that dissolve after healing is completed can boost the market.

Threats:
- Availability of alternative treatment options such as external fixation devices, plating systems acts as a threat.
- Strong competition from key players may decrease profit margins.

Key Takeaways

The  Global Intramedullary Nail Market Size is expected to witness high growth. It was valued at US$ 1.95 Bn in 2023 and is projected to reach US$ 3.29 Bn by 2030, expanding at a CAGR of 8.5% during the forecast period.

Regional analysis

North America currently dominates the market owing to growing geriatric population and high prevalence of osteoporosis in the US and Canada. However, Asia Pacific is expected to be the fastest growing region due to rising healthcare infrastructure, disposable incomes and increasing road accidents in major countries like China and India.

Key players

Key players operating in the intramedullary nail market are Zimmer Biomet, Smith & Nephew, Stryker, DePuy Synthes, Orthofix, Bioventus LLC, DJO Global, Braun, Medtronic, and Globus Medical. Zimmer Biomet and Stryker together hold over 50% of the global market share due to strong brand presence and wider product portfolio.

Get More Insights On This Topic: https://www.feedsfloor.com/market-research/global-intramedullary-nail-market-growth-accelerated-increased-usage-trauma